267 related articles for article (PubMed ID: 15377059)
1. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Riordan HD; Riordan NH; Jackson JA; Casciari JJ; Hunninghake R; González MJ; Mora EM; Miranda-Massari JR; Rosario N; Rivera A
P R Health Sci J; 2004 Jun; 23(2):115-8. PubMed ID: 15377059
[TBL] [Abstract][Full Text] [Related]
2. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.
Ohno S; Ohno Y; Suzuki N; Soma G; Inoue M
Anticancer Res; 2009 Mar; 29(3):809-15. PubMed ID: 19414313
[TBL] [Abstract][Full Text] [Related]
3. [Vitamin C in complementary oncology--update 2009].
Gröber U
Med Monatsschr Pharm; 2009 Jul; 32(7):263-7. PubMed ID: 19731754
[TBL] [Abstract][Full Text] [Related]
4. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.
González MJ; Miranda-Massari JR; Mora EM; Jiménez IZ; Matos MI; Riordan HD; Casciari JJ; Riordan NH; Rodríguez M; Guzmán A
P R Health Sci J; 2002 Mar; 21(1):39-41. PubMed ID: 12013679
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid in the prevention and treatment of cancer.
Head KA
Altern Med Rev; 1998 Jun; 3(3):174-86. PubMed ID: 9630735
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ascorbic acid: protocol for its application and use.
Riordan HD; Hunninghake RB; Riordan NH; Jackson JJ; Meng X; Taylor P; Casciari JJ; González MJ; Miranda-Massari JR; Mora EM; Rosario N; Rivera A
P R Health Sci J; 2003 Sep; 22(3):287-90. PubMed ID: 14619456
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer.
Stephenson CM; Levin RD; Lis CG
J Am Osteopath Assoc; 2007 Jun; 107(6):212-3. PubMed ID: 17635899
[No Abstract] [Full Text] [Related]
8. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
Hoffer LJ; Robitaille L; Zakarian R; Melnychuk D; Kavan P; Agulnik J; Cohen V; Small D; Miller WH
PLoS One; 2015; 10(4):e0120228. PubMed ID: 25848948
[TBL] [Abstract][Full Text] [Related]
9. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD; Casciari JJ; González MJ; Riordan NH; Miranda-Massari JR; Taylor P; Jackson JA
P R Health Sci J; 2005 Dec; 24(4):269-76. PubMed ID: 16570523
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. [Current views on tumor treatment with large doses of vitamin C].
Płomiński P; Stepka K
Wiad Lek; 1982 Sep; 35(14):889-93. PubMed ID: 6755919
[No Abstract] [Full Text] [Related]
13. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
14. Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 Jun; 158(11):1483-8. PubMed ID: 9629113
[No Abstract] [Full Text] [Related]
15. Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.
Dean E; Jodrell D; Connolly K; Danson S; Jolivet J; Durkin J; Morris S; Jowle D; Ward T; Cummings J; Dickinson G; Aarons L; Lacasse E; Robson L; Dive C; Ranson M
J Clin Oncol; 2009 Apr; 27(10):1660-6. PubMed ID: 19237630
[TBL] [Abstract][Full Text] [Related]
16. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
Shahrbanoo K; Taziki O
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of cancer in the elderly].
Bangerter M; Heinrich B; Brudler O
MMW Fortschr Med; 2004 Sep; 146(40):30-2. PubMed ID: 15529665
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly.
Wasil T; Lichtman SM
Oncologist; 2005 Sep; 10(8):602-12. PubMed ID: 16177284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
